Trials / Completed
CompletedNCT02987985
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy: a Pilot Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Saskatchewan · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.
Detailed description
The objective of this trial is to determine whether an opioid-free general anesthetic can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques.
Conditions
- Anesthesia
- General Anesthesia
- Analgesics, Opioid
- Postoperative Complications
- Pathologic Processes
- Physiologic Effects of Drugs
- Narcotics
- Analgesics
- Sleep Disordered Breathing
- Obstructive Sleep Apnea of Child
- Tonsillectomy
- Respiratory Depression
- Dexmedetomidine
- Ketamine
- Lidocaine
- Gabapentin
- Pulse Oximetry
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetaminophen, gabapentin | acetaminophen 15 mg/kg, gabapentin 10 mg/kg |
| DRUG | Acetaminophen | acetaminophen 15 mg/kg |
| DRUG | Ketamine , Lidocaine , Dexmedetomidine | Ketamine 0.5 mg/kg, Lidocaine 1 mg/kg, Dexmedetomidine 0.3 mcg/kg |
| DRUG | Fentanyl, Dexmedetomidine | Fentanyl 0.5 mcg/kg, Dexmedetomidine 0.3 mcg/kg |
| DRUG | Dexamethasone , Ondansetron | Dexamethasone 150 mcg/kg, Ondansetron 50 mg/kg |
| DRUG | Sevoflurane | Sevoflurane (dose titrated to effect) |
| DRUG | Sevoflurane, Fentanyl | Sevoflurane (dose titrated to effect), Fentanyl as needed (dose at anesthesiologist's discretion) |
Timeline
- Start date
- 2017-10-15
- Primary completion
- 2019-09-20
- Completion
- 2020-12-20
- First posted
- 2016-12-09
- Last updated
- 2021-08-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02987985. Inclusion in this directory is not an endorsement.